Merck Hepatitis C Drug to Enter Crowded Field With High PricesBy and
FDA approves drug that will compete against Gilead, AbbVie
Agency says Merck drug approved for genotypes 1 and 4
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.